https://orcid.org/0000-0001-7033-0417
References
- Hammer H, Bader BM, Ehnert C, et al. A multifaceted GABAA receptor modulator: functional properties and mechanism of action of the sedative-hypnotic and recreational drug methaqualone (Quaalude). Mol Pharmacol. 2015;88(2):401–420.
- Ionescu-Pioggia M, Bird M, Orzack MH, et al. Methaqualone. Int Clin Psychopharmacol. 1988;3(2):97–109.
- Saito C, Sakai S, Yukawa Y, et al. Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4[H)-quinazolinone (SL-164). Arzneimittelforschung. 1969;19:1945–1949.
- Yamamoto H, Inaba S, Arasaki S, et al. Compositions and methods for tranquilizing with substituted 3-phenyl-4-quinazolinone derivatives. Patent No. US3651230A. Sumitomo Chemical Co., Ltd., Osaka, Japan, 1972.
- Ceschi A, Giardelli G, Müller DM, et al. Acute neurotoxicity associated with recreational use of methylmethaqualone confirmed by liquid chromatography tandem mass spectrometry. Clin Toxicol. 2013;51(1):54–57.
- Brown SS, Goenechea S. Methaqualone: metabolic, kinetic, and clinical pharmacologic observations. Clin Pharmacol Ther. 1973;14(3):314–324.
- Kurz RW, Hainz R, Gremmel F, et al. Dangerous intoxication from extreme serum concentrations of methaqualone metabolites. Detection and quantification of biosynthesis with gas chromatography-mass spectrometrys. Anaesthesist. 1995;44(12):863–868.
- Abboud RT, Freedman MT, Rogers RM, et al. Methaqualone poisoning with muscular hyperactivity necessitating the use of curare. Chest 1974;65(2):204–205.